ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment

January 25, 2013

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

In Brief: Cigarette Tax Would Raise $12 Million A Year for Pennsylvania Cancer Control, Research

August 5, 1977

“Long Overdue” Efforts By States Urged To Help Fund Community, Regional Cancer Control Efforts

August 4, 1978

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004